Works by ZHOU, X.-L.


Results: 47
    1
    2
    3
    4
    5

    P942: DREAMM‐9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT‐INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2022, v. 6, p. 832, doi. 10.1097/01.HS9.0000846636.06566.b4
    By:
    • Usmani, S. Z.;
    • Mielnik, M.;
    • Koh, Y.;
    • Alonso Alonso, A.;
    • Leleu, X.;
    • Quach, H.;
    • Min, C.‐K.;
    • Janowski, W.;
    • Abdallah, A.‐O.;
    • Garg, M.;
    • Sandhu, I.;
    • Ocio San Miguel, E. M.;
    • Oriol, A.;
    • Rodriquez‐Otero, P.;
    • Ramasamy, K.;
    • Weisel, K.;
    • Besemer, B.;
    • Cavo, M.;
    • Zhou, X. L.;
    • Kaisermann, M. C.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47